StockData
Adastra Holdings Ltd. logo

Adastra Holdings Ltd. (XTXXF) stock

XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Adastra r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2022 it was C$0, down 100.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2022Dec 31, 2022C$0-100.0%
FY2021Dec 31, 2021C$89.27K-50.9%
FY2020Dec 31, 2020C$181.75K–

More Adastra figures

See a number that looks wrong?